The company removed the devices from the market in February following complaints of the syringes disconnecting from manifolds ...
Medline (Nasdaq:MDLN) has received a warning letter from the FDA related to NAMIC brand angiographic control syringes and ...
After Medline pulled off a massive $6.26 billion IPO late last year, the company now finds itself facing serious concerns ...
Medline (MDLN) stock is in focus as the FDA warns the company over issues related to the production of NAMIC Angiographic ...
Food and Drug Administration has warned medical device maker Medline that its syringes used in heart procedures are ...
Hosted on MSN
If you're sick of waiting for a new Splinter Cell, this indie stealth game might fill the gap
It's been nearly thirteen years since we last saw a Splinter Cell game, and there's little chance of another one appearing any time soon. A remake of the original Splinter Cell is supposedly in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results